According to Foghorn Therapeutics's latest financial reports the company's current revenue (TTM ) is $35.18 Million USD. In 2023 the company made a revenue of $34.15 Million USD an increase over the revenue in the year 2022 that were of $19.22 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.